Home | Welcome to Contract Pharma   
Last Updated Tuesday, October 21 2014
Print

Breaking News

Related Searches:
January 25, 2011
Worldwide Pharmaceutical sales were $22.4 billion for the year (-1%).   Read More »
January 25, 2011
U.S. product sales were flat at $2.9 billion in the quarter and included a $65 million unfavorable impact due to U.S. health care reform.  Read More »
January 25, 2011
Amgen has entered into a definitive agreement to acquire BioVex Group, Inc., a privately held biotechnology company headquartered in Woburn, MA.   Read More »
January 25, 2011
John H. Johnson has been named chief executive officer of Savient Pharmaceuticals, Inc., effective January 31, 2011.   Read More »
January 25, 2011
Sanofi-aventis has acquired an exclusive worldwide license to one of Oxford BioTherapeutics’ (OBT) preclinical antibody programs.  Read More »
January 24, 2011
MuDelta to get accelerated review  Read More »
January 24, 2011
Will link with global early-phase ops   Read More »
January 24, 2011
Diagnostics firm to join MDx unit  Read More »
January 24, 2011
New international pharma intermediates VP  Read More »
January 21, 2011
inVentiv Health, Inc. has signed a definitive agreement to acquire Campbell Alliance, a management consulting firm serving the pharmaceutical and biotech industries.   Read More »
January 21, 2011
Covance’s genomics lab in Seattle, WA received Clinical Laboratory Improvement Amendment (CLIA) certification from the State of Washington Department of Health.  Read More »
January 21, 2011
OYSTAR GmbH has restructured, creating OYSTAR North America.  Read More »
January 20, 2011
Genzyme Corp. will build an additional manufacturing plant in Geel, Belgium, to support the long-term growth of Myozyme and Lumizyme for Pompe disease.  Read More »
January 20, 2011
Evotec AG has entered into a collaboration with Takeda Cambridge Ltd., to identify small molecule modulators against GPCR and Protease targets to treat various CNS and Metabolic diseases.  Read More »
January 20, 2011
inVentiv Health has signed a definitive agreement to acquire the i3 clinical development businesses from Ingenix.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On